BSX Stock: Price, Earnings History and SEC Filings
Boston Scientific Corporation (BSX) last traded at $41.98, down 1.66% on the latest session and down 3.8% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $0.73 against an analyst estimate of $0.73, a beat of 0.0%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
BSX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 28, 2026 | $0.73 | $0.73 | +0.00% |
| Jun 2026 | Jul 29, 2026 | $0.86 | $0.83 | +3.61% |
| Mar 2026 | Apr 22, 2026 | $0.80 | $0.80 | +0.00% |
| Dec 2025 | Feb 4, 2026 | $0.80 | $0.78 | +2.56% |
BSX beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
How BSX reacts to earnings
Across its last 8 earnings releases, BSX moved 5.8% on average the next session, in either direction. It rose after 5 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-10-28 | Before open | -5.84% |
| 2026-07-29 | Before open | -0.04% |
| 2026-04-22 | Before open | +8.99% |
| 2026-02-04 | Before open | -17.59% |
| 2025-10-22 | Before open | +3.95% |
| 2025-07-23 | Before open | +4.46% |
| 2025-04-23 | Before open | +4.07% |
| 2025-02-05 | Before open | +1.38% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
BSX financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $20.1B | – | $3.7B | – | $1.94 |
| 2024 | $16.7B | – | $2.6B | – | $1.25 |
| 2023 | $14.2B | – | $1.8B | – | $1.07 |
| 2022 | $12.7B | – | $938M | – | $0.45 |
| 2021 | $11.9B | – | $1.3B | – | $0.69 |
| 2020 | $9.9B | – | $1.1B | – | $-0.08 |
| 2019 | $10.7B | – | $1.4B | – | $3.33 |
| 2018 | $9.8B | – | -$6M | – | $1.19 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for BSX
- 8-K · Oct 28, 2026Results of operations, Financial statements and exhibits
- 8-K · Oct 7, 2026Officer or director change, Other events, Financial statements and exhibits
- 8-K · Sep 23, 2026Officer or director change
- 8-K · Sep 8, 2026
- 8-K · Aug 26, 2026Other events
- 10-Q · Aug 3, 2026
- 8-K · Jul 29, 2026Results of operations, Financial statements and exhibits
- 8-K · Jul 27, 2026
- 8-K · May 18, 2026Other events, Financial statements and exhibits
- 8-K · May 18, 2026Other events, Financial statements and exhibits
Insider filing activity
BSX insiders filed 7 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
BSX news
- Intuitive Surgical vs. Boston Scientific: Which Stock Is a Better Buy Now?Oct 30, 2026 · finance.yahoo.com
- JNJ's MedTech Segment Disappoints in Q3: Will Growth Rebound in Q4?Oct 30, 2026 · finance.yahoo.com
- Buy, Sell, or Hold? Today’s Top Upgrades and Downgrades: Boston Scientific, DoorDash, GE Vernova, Honeywell Aerospace, Incyte. Intel, Reddit, Rivian Automotive, and MoreOct 30, 2026 · 247wallst.com
- New Strong Sell Stocks for October 30thOct 30, 2026 · finance.yahoo.com
- Cyberattack Fallout Could Be A Game Changer For Boston Scientific (BSX)Oct 29, 2026 · finance.yahoo.com
- Penumbra, Inc. Reports Third Quarter 2026 Financial ResultsOct 29, 2026 · finance.yahoo.com
- Boston Scientific (BSX) Wins FDA Clearances, Starts Elite AF Trial And Expands AI PushOct 29, 2026 · finance.yahoo.com
- Podcast: Boston Scientific on the growing importance of clinical evidence in cardiologyOct 29, 2026 · medicaldevice-network.com
About Boston Scientific Corporation
Boston Scientific Corporation (BSX) is a US-listed public company on NYSE. The SEC classifies its business as Surgical & Medical Instruments & Apparatus. It is incorporated in DE. Its fiscal year ends in December.